Dong-A estimated 605.5 BW of sales and 50 BW of ordinary incomes in 2005.

Dong-A tentatively reported the sales and ordinary incomes of 2005 at 605 billion won and 50 billion won respectively largely due to the remarkable growth of Styrene and Nicetil.

The company announced to launch the total 12 new prescription drugs for the treatment of cerebral blood flow improvement, infertility, acute pulmonary disorders and diabetic and 1 non-prescription drug in the new ye...